Stockreport

Melinta down 12% premarket on EPS miss [Seeking Alpha]

MELINTA THERAPEUTICS INC  (MLNT) 
Last melinta therapeutics inc earnings: 11/12 04:39 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations
PDF Melinta Therapeutics ( MLNT ) Q2 results : Revenues: $16M (+33.3%); Product sales: $13.8M (+50.0%); Contract research: $2.1M (-27.6%). Net Loss: ($36.2M) (+35 [Read more]